Hangzhou Tigermed Consulting Co., Ltd.
HNGZY · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $25,166 | $25,794 | $68,601 | $70,325 |
| - Cash | $2,055 | $7,420 | $7,858 | $8,544 |
| + Debt | $2,635 | $2,827 | $2,801 | $1,189 |
| Enterprise Value | $25,746 | $21,201 | $63,545 | $62,970 |
| Revenue | $6,603 | $7,384 | $7,085 | $5,214 |
| % Growth | -10.6% | 4.2% | 35.9% | – |
| Gross Profit | $2,242 | $2,849 | $2,808 | $2,271 |
| % Margin | 34% | 38.6% | 39.6% | 43.6% |
| EBITDA | $1,130 | $2,847 | $2,953 | $3,895 |
| % Margin | 17.1% | 38.5% | 41.7% | 74.7% |
| Net Income | $405 | $2,025 | $2,007 | $2,874 |
| % Margin | 6.1% | 27.4% | 28.3% | 55.1% |
| EPS Diluted | 0.47 | 2.34 | 2.32 | 3.3 |
| % Growth | -79.9% | 0.9% | -29.7% | – |
| Operating Cash Flow | $1,097 | $1,150 | $1,358 | $1,424 |
| Capital Expenditures | -$357 | -$314 | -$449 | -$369 |
| Free Cash Flow | $740 | $837 | $909 | $1,055 |